contours of the pancreas. In hypertrophic pancreatitis, the pancreatic arteries are displaced and deformed, and enlargement of the pancreas becomes obvious, especially in the capillary phase. Subacute pancreatitis shows inflammatory hypervascularity and increased density of the enlarged pancreas. Irregular appearance with uneven width and deformity of pancreatic arteries are signs of chronic pancreatitis. These changes are usually diffuse, but they may be localized and then the differentiation between the inflammatory and tumour processes is very difficult.
A characteristic picture is offered by the pseudocyst and it is revealed by displacement of surrounding vessels and by the absence of vascular supply at the site of the cyst. The pseudocyst of the head usually displaces the gastroduodenal artery to the right, while the inferior pancreaticoduodenal arteries are pushed downwards. However, the gastroduodenal artery can be displaced to the left and its branches encircle the cyst. The pseudocyst of the tail displaces the splenic artery and its pancreatic branches and there is an avascular region at its site.
Arteriography helps in differentiation between a pseudocyst and a cyst of tumorous origin, the cystadenoma. This is very vascular and the displaced deformed branches in its vicinity supply many irregular tumour vessels forming a rich network in the wall of the cystadenoma.
The main sign of malignant tumour is neoplastic invasion of vessels. Since this occurs early, arteriography helps in early diagnosis. The small pancreatic arteries are affected first. They are irregular, with indented outlines and often amputated. This amputation is characteristic for a cancer and if it is noted the differentiation can be made between a tumour and inflammation.
Larger tumours also affect major arterial trunks. In the head, the gastroduodenal artery is often infiltrated and the hepatic artery can be displaced by an enlarged gall-bladder. The tumours of the body often invade the upper part of the superior mesenteric and medial section of the hepatic and splenic arteries. The later venous phase often shows obstruction of the portal vein with gastric varices. The splenic artery and sometimes also the mesenteric artery are invadedirregularly narrowed and rigidby the tumours of the tail.
Another sign of pancreatic cancer is the tumour neovascularity. It does not appear as regularly as infiltration but, with improved technique and using more contrast medium, we see it more often than was previously considered. The new-formed vessels are fine, tortuous, irregular, and may form networks or appear as arteriovenous communications with early filling of small venous sinuses. The filling of new-formed vessels often persists and there can be tumour staining in the capillary phase.
The tumour neovascularity, however, is very extensive in less common malignant tumours such as sarcoma or islet cell carcinoma and appears together with infiltration or even complete obstruction of vessels.
Arteriography is very important also in the diagnosis of islet cell tumours and their clinical manifestationsin the diagnosis of hyperinsulinism and Zollinger-Ellison syndrome. Many of the islet cell tumours are vascular with fine newformed vessels and appear as hypervascularized foci in the vascular phase and as sharply dense foci in the capillary phase. In larger tumours the neovascularity is often very extensive and supplied by enlarged vessels. With malignant degeneration, there is usually irregularity of tumour margins and hepatic metastases appear. They have the same appearance of dense foci with uneven margins.
Angiography represents an important step in pancreatic diagnosis, Starting with the splenoportography and inferior caval phlebography and culminating with the arteriography, it substantially improves the diagnosis of pancreatic lesions. The diagnostic accuracy of the new arteriographic technique is about 80-85 %. The main problem is the differentiation between inflammation and tumour and their frequent coexistence makes this problem more difficult. However, there are still ways for further improvement with pharmacoangiography and direct magnification of the picture representing the most promising ones.
Dr Ian A D Bouchier (Royal Free Hospital, London)
Pancreatic Scanning With the introduction of 75Se-selenomethionine as an agent for scanning it has become possible to visualize the pancreas (Blau et al. 1962) . The incorporation of selenium-75 into methionine results in a compound which emits gamma radiation and can be used for scintillation scanning. The radioactive selenomethionine is treated initially like the parent amino acid in vivo.
No preparation of the patient is necessary and the patient is not fasted; 3 pCi 7"Se-selenomethionine/kg body weight is injected intravenously and the patient is scanned in the supine position some 40 minutes later. A Picker Magna-Scanner is used with a 12f5 x 5 cm sodium iodide crystal, an 85-hole collimator of nominal focal length 12-5 cm and a standard scanning speed of 24 cm/sec. The machine gives both a photoscan (black and white) and a scintigram (colour) printout. Liver size and position are determined by doing a 198Au-colloidal gold scan after the pancreatic scan (Melmed et al. 1968 ). The normal pancreatic scan: The isotope is distributed evenly through the gland with the exception of an area of decreased uptake in the neck of the pancreas. There is marked variation in the position of the body and tail. Reproducibility of the scan is satisfactory. Pancreatic tumQurs: Either a circumscribed filling defect is seen or there is diffuse failure of isotope uptake. In the Zollinger-Ellison syndrome there may be increased isotope uptake; insulinomas manifest as filling defects (Brown et al. 1968 ). Pancreatitis: In the acute episode there may be failure of isotope uptake in part or the whole of the pancreas. The scan may revert to normal within three weeks of an attack. The scan is abnormal in about 75 % of patients with chronic pancreatitis.
Distortion of the pancreatic outline may occur with extrapancreatic lesions such as retroperitoneal tumours and aneurysms of the abdominal aorta. There may be diffuse failure of isotope uptake in genetic diabetes mellitus and following prolonged fasting, vagotomy or gastric surgery.
Uptake of 75Se-selenomethionine by the bowel or liver usually does not give rise to interpretative difficulties unless there is overlap of the pancreas by the liver. This may occur as an anatomical variant but is a constant feature when there is hepatomegaly. Under these circumstances it is usually possible to give an interpretative comment by studying reinforcement patterns. However, about 10% of all scans are unreadable and a further 10% are interpreted with little confidence. Subtraction techniques have been used to overcome these difficulties (Eaton et al. 1967) .
We have attempted to improve our diagnostic accuracy in the following ways:
(1) The pancreatic scan has been combined with hypotonic duodenography. In a study of 50 patients using correlated duodenography and photoscans the scan reporting was rendered more objective in 50% of cases ).
(2) Isotope activity has been counted over set areas of liver, pancreas and bowel and expressed as absolute values and ratios. We have found that usually this information does not add to the diagnostic accuracy of reporting (Agnew et al. 1969 ), although occasionally it may be helpful when taken in the context of other data.
(3) On theoretical grounds 7"Se-selenocystine might be a suitable agent for scanning the pancreas. Experiments were undertaken in both rabbits and man using DLrqeso-and L-selenocystine. A significant fraction of the dose is rapidly cleared by the kidney but the pancreatic uptake is poor. Neither compound offers any advantage over 7"Se-L-selenomethionine (Melmed etal. 1969) .
As currently practised pancreatic scanning complements other techniques for investigatg pancreatic morphology and function. When the scan is abnormal it is usually not possible to tell with certainty the nature of the pathology solely on the appearance of the isotope uptake. In our experience a normal scan is very good grounds for excluding disease in the gland. The principal aims of pancreatic arteriography can be defined as: (1) The demonstration of early, still resectable malignancy. (2) A convincing display of pancreatic arterial normality.
Dr HS Herlg
The coeliac and supenror mesenteric arteries supply relatively minor branches to the pancreatic framework. Arteries to the stomach, duodenum, jejunum or transverse colon may obscure the tenuous vascular characteristics of an early pancreatic carcinoma. Subselective catheterization is not always possible; in the elderly arteriopath a midstream aortogram may be all that can be achieved.
Angiotomography can be employed to free the pancreas from this obscuring overlay. Interpretation of angiotomograms is often difficult and overdiagnosis must be avoided. Single sweep angiotomograms are inadequate as timing is uncertain and more than one phase of filling needs to be studied. A device for serial angiotomography constructed in Leeds in 1965 and demonstrated to the British Institute of Radiology in 1966 has been considerably improved. It now accommodates six multisection cassettes and takes only 1-3 seconds between the starts of successive exposures. The first sweep can be done before injection commences and makes possible a photographic subtraction of the later films. This is a useful method which will eliminate part of the detail-obscuring smear lines associated with linear movement tomography.
[Slides were shown to illustrate the value of pancreatic angiotomography. A cine film explained the operation of the apparatus for time sequence angiotomogaphy and demonstrated its use during an examination.] "This work will be more fully reported elsewhere
